- $1.69bn
- $1.25bn
- $364.99m
Annual income statement for WEALTHFRONT, fiscal year end - January 31st, USD millions except per share, conversion factor applied.
2024 January 31st | 2025 January 31st | 2026 January 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Revenue | |||
| Total Revenue | 217 | 309 | 365 |
| Cost of Revenue | |||
| Gross Profit | 194 | 278 | 327 |
| Selling / General / Administrative Expenses | |||
| Research And Development | |||
| Unusual Expense / Income | |||
| Total Operating Expenses | 135 | 187 | 476 |
| Operating Profit | 81.6 | 121 | -111 |
| Total Net Non Operating Interest Income / Expense | |||
| Other Net Non Operating Costs | |||
| Net Income Before Taxes | 78.6 | 139 | -101 |
| Provision for Income Taxes | |||
| Net Income After Taxes | 77 | 194 | -42.1 |
| Net Income Before Extraordinary Items | |||
| Net Income | 77 | 194 | -42.1 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Diluted Net Income | 77 | 194 | -42.1 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | 0.526 | 1.33 | -0.277 |